Few people actually benefit from ‘breakthrough’ cancer immunotherapy – STAT
STAT |
Few people actually benefit from 'breakthrough' cancer immunotherapy
STAT When immunotherapy works, the result is terrific, even life-changing. Today, though, only a tiny minority of patients expected to die from cancer will benefit from immunotherapy. As is often the case, hype sadly exceeds evidence, creating … Roy S. Herbst, MD, PhD, on Lung Cancer With Immune Checkpoints: Promising Combinations |
